MTOR and breast cancer: Our results, on the contrary, suggest that increase in abnormal CpG island methylation driven by HER2 is mediated by PI3K/AKT/mTOR pathway leading to enhanced proliferation and rapid tumor evolution with accumulation of CpG island hypermethylation that is not directly functional in BC pathogenesis.